JPS6218559B2 - - Google Patents
Info
- Publication number
- JPS6218559B2 JPS6218559B2 JP53111780A JP11178078A JPS6218559B2 JP S6218559 B2 JPS6218559 B2 JP S6218559B2 JP 53111780 A JP53111780 A JP 53111780A JP 11178078 A JP11178078 A JP 11178078A JP S6218559 B2 JPS6218559 B2 JP S6218559B2
- Authority
- JP
- Japan
- Prior art keywords
- ornithine
- hydroxyarginine
- lysine
- threonine
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WBVFBXZGHGWBRE-RZOMMOEVSA-N (2r)-2-[[(2s)-6-amino-2-[[(2r)-5-amino-2-[[(2s,3r)-2-[[(2r)-5-amino-2-[[(2s,4s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)-4-hydroxypentanoyl]amino]pentanoyl]amino]-3-hydroxybutanoyl]amino]pentanoyl]amino]hexa Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C[C@H](O)CN=C(N)N)C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](CCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(O)=O)CC1=CC=C(O)C=C1 WBVFBXZGHGWBRE-RZOMMOEVSA-N 0.000 claims description 32
- DETXZQGDWUJKMO-UHFFFAOYSA-N 2-hydroxymethanesulfonic acid Chemical compound OCS(O)(=O)=O DETXZQGDWUJKMO-UHFFFAOYSA-N 0.000 claims description 23
- 150000001413 amino acids Chemical group 0.000 claims description 11
- 239000004472 Lysine Substances 0.000 claims description 10
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 7
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 7
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 6
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229960003104 ornithine Drugs 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 5
- WQFIAVZQVYASHZ-BYPYZUCNSA-N (2s)-5-(diaminomethylideneamino)-2-(hydroxyamino)pentanoic acid Chemical compound NC(=N)NCCC[C@H](NO)C(O)=O WQFIAVZQVYASHZ-BYPYZUCNSA-N 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- -1 hydroxyarginine-ornithine-threonine-ornithine-lysine Chemical compound 0.000 claims description 3
- 239000002262 Schiff base Substances 0.000 claims description 2
- 150000004753 Schiff bases Chemical class 0.000 claims description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 description 13
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- KKVTYAVXTDIPAP-UHFFFAOYSA-M sodium;methanesulfonate Chemical compound [Na+].CS([O-])(=O)=O KKVTYAVXTDIPAP-UHFFFAOYSA-M 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 241000223250 Metarhizium anisopliae Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- OQCZIHUBJQDIQI-ZCFIWIBFSA-N (2r)-2-amino-5-(diaminomethylideneamino)-2-hydroxypentanoic acid Chemical compound NC(=N)NCCC[C@@](N)(O)C(O)=O OQCZIHUBJQDIQI-ZCFIWIBFSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241000223201 Metarhizium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000840267 Moma Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11178078A JPS5547697A (en) | 1978-09-13 | 1978-09-13 | Aldehyde bisulfite adduct of peptide antibiotic k582m-a and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11178078A JPS5547697A (en) | 1978-09-13 | 1978-09-13 | Aldehyde bisulfite adduct of peptide antibiotic k582m-a and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5547697A JPS5547697A (en) | 1980-04-04 |
| JPS6218559B2 true JPS6218559B2 (fi) | 1987-04-23 |
Family
ID=14569969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11178078A Granted JPS5547697A (en) | 1978-09-13 | 1978-09-13 | Aldehyde bisulfite adduct of peptide antibiotic k582m-a and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5547697A (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5811812A (ja) * | 1981-07-16 | 1983-01-22 | Yokogawa Hokushin Electric Corp | メモリ一式のレコ−ダ |
| US4507740A (en) * | 1981-09-08 | 1985-03-26 | Grumman Aerospace Corporation | Programmable signal analyzer |
| JPS6240538U (fi) * | 1985-08-30 | 1987-03-11 | ||
| JP4875415B2 (ja) * | 2006-06-27 | 2012-02-15 | 有限会社清田製作所 | コンタクトプローブ |
-
1978
- 1978-09-13 JP JP11178078A patent/JPS5547697A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5547697A (en) | 1980-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH02288887A (ja) | テイコマイシンａ↓２純粋単―ファクタ―３ | |
| JPS59130888A (ja) | 結晶質セフエム−酸付加塩およびその製造方法 | |
| JPH029885A (ja) | セファロスポリン塩および注射可能な組成物 | |
| RU2476436C1 (ru) | Комплексные соединения германия с аминокислотами и карбоновыми кислотами | |
| JPS6218559B2 (fi) | ||
| US5770733A (en) | Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained | |
| IE902656A1 (en) | Salts of n5,n10-methylene-5,6,7,8-tetrahydrofolic acid | |
| CA1254903A (en) | Salts of oxazaphosphorine derivatives and their preparation | |
| NO138026B (no) | Analogifremgangsm}te til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner | |
| US4056672A (en) | Polymer prepared by cyanhydrin method | |
| JPS604189B2 (ja) | 抗菌剤およびその製法 | |
| JPS606958B2 (ja) | 抗生物質の精製法 | |
| KR880000133B1 (ko) | 악타플라닌 항생물질의 제조방법 | |
| US2659733A (en) | Process of producing butyrolactones | |
| EP0158879B1 (en) | Compounds having cardiotrophic activity, a process for the preparation thereof and pharmaceutical compositions therefrom | |
| JP3216056B2 (ja) | 免疫能賦活化物質、水溶性パラミロンおよびその製造方法 | |
| RU1831471C (ru) | Способ получени комплексных соединений псевдопримицина | |
| EP0268271B1 (en) | Metal complexes of n-acetyl-glucosaminyl-n-acetal-muramoyl-l-alanyl-d-isoglutaminyl-(l)-meso-diamino-pimelyl-(d-amide)-(l)-d-alanyl-d-alanine and their use in the manufacture of pharmaceuticals | |
| SU825542A1 (ru) | Способ получения n-производных полисахаридов 1 | |
| JP3156135B2 (ja) | 免疫賦活用活性物質及びその製造法 | |
| JP2690779B2 (ja) | Ｌ―アスコルビン酸誘導体及びその製造法 | |
| CA1110266A (en) | N-(phosphonoacetyl)-l-aspartic acid compounds and methods for their preparation | |
| KR790001550B1 (ko) | 아미노산의 제조방법 | |
| AU700833B2 (en) | Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained | |
| KR820000809B1 (ko) | 신규 피리딘 유도체의 제조방법 |